Drug intelligence / Profile preview

tokuyama shield force plus

Development stage: Phase 3
Lead developer: Tokuyama Dental
Modality: Small Molecules
Administration: Dental

Overview

TOKUYAMA SHIELD FORCE PLUS is a one-component, single application, light-cured, fluoride-releasing desensitizer designed for the treatment of hypersensitive dentin. It effectively infiltrates and seals exposed dentinal tubules to inhibit the flow of fluid through the tubules which causes sensitivity. The durable coat of cured material helps prevent loss of dentin due to abrasion and/or erosion. It features a "Double Block Technology" that provides two layers of protection: the first layer penetrates dentinal tubules for immediate relief, while the second forms a protective barrier against future sensitivity for up to 3 years.

Brand names: TOKUYAMA SHIELD FORCE PLUSShield Force Plus

Beyond the preview

Go deeper on tokuyama shield force plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tokuyama shield force plus.

Explore the full profile